AbCellera Biologics Inc.

ABCL · Healthcare

$11.28

Markedsværdi: 3.66B USDUdbytteafkast: —
AdvancedEr det et godt tidspunkt at købe AbCellera Biologics Inc.? Spørg Copenvest AIFå et Advanced AI-bud på timing, risiko og hvad tracked investorer gør.Spørg Copenvest AI

Indlæser diagram…

Nyheder

Seneste overskrifter for denne aktie

Business Wire2. sep. 2026, 20.05

AbCellera to Present at the Cantor Global Healthcare Conference on September 9, 2026

Business Wire31. aug. 2026, 16.03

BostonGene to Showcase Novel Genomic Classifier and Immunotherapy Selection Framework at SOHO 2026

Insider Monkey16. aug. 2026, 01.09

AbCellera (ABCL) Soars 64% as Drug Candidate Holds Huge Market Opportunity

Insider Monkey14. aug. 2026, 22.53

Can AbCellera Biologics (ABCL)’s Vertex Pharmaceuticals Incorporated (VRTX) Deal Turn its TCE Platform Into a Breakthrough?

MT Newswires13. aug. 2026, 08.15

AbCellera Biologics Prices $200 Million Offering of Shares, Pre-Funded Warrants